Given its extensive portfolio of opthalmic and facial aesthetic products Allergan is well positioned to take advantage of the increased demand in these markets that will be driven by baby boomers over the next several years.
Allergan's recently approved silicone-filled breast implants represent a major victory as these products have been banned in the US for over 15 years. This gives Allergan a first mover's advantage of sorts.